672 related articles for article (PubMed ID: 16973090)
21. [Adjuvant therapy of breast cancer].
Semiglazov VF; Abzumanov AS; Bozhok AA; Ivanov VG; Ivanova OA; Barash NIu; Topuzov EE; Seleznev IK; Migmanova NSh; Popova RT; Nurgaziev KSh
Khirurgiia (Mosk); 2001; (5):52-60. PubMed ID: 11505673
[No Abstract] [Full Text] [Related]
22. Infiltrating lobular carcinoma of the breast: systemic treatment.
Farese SA; Aebi S
Breast Dis; 2008-2009; 30():45-52. PubMed ID: 19850995
[TBL] [Abstract][Full Text] [Related]
23. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.
Cunnick GH; Mokbel K
Lancet; 2003 Oct; 362(9390):1154; author reply 1155-6. PubMed ID: 14550707
[No Abstract] [Full Text] [Related]
24. The optimal duration of adjuvant hormonal therapy for early-stage breast cancer.
Winer E
Clin Adv Hematol Oncol; 2008 Aug; 6(8):573-4. PubMed ID: 18820598
[No Abstract] [Full Text] [Related]
25. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.
Baroni G; Pedotti A; Orecchia R
Lancet; 2003 Oct; 362(9390):1155; author reply 1155-6. PubMed ID: 14550709
[No Abstract] [Full Text] [Related]
26. [A case regarded as an occult breast cancer treated without mastectomy].
Kawashima T; Miyazawa Y; Sakata H; Matsubara H; Ryu M; Ochiai T
Gan To Kagaku Ryoho; 2005 Jun; 32(6):825-8. PubMed ID: 15984524
[TBL] [Abstract][Full Text] [Related]
27. Ductal carcinoma in situ--current management.
O'Sullivan MJ; Morrow M
Surg Clin North Am; 2007 Apr; 87(2):333-51, viii. PubMed ID: 17498530
[TBL] [Abstract][Full Text] [Related]
28. [Hormonal therapy in breast cancer].
Espinós J; Reyna C; de la Cruz S; Oiler C; Hernández A; Fernández Hidalgo O; Santisteban M; García Foncillas J
Rev Med Univ Navarra; 2008; 52(1):40-8. PubMed ID: 18578196
[TBL] [Abstract][Full Text] [Related]
29. Multiple lymphatic-type, atypical vascular lesions of the breast following radiation therapy.
Kim PS; Neff AG; Mutasim DF; Spicknall KE
Int J Dermatol; 2013 Feb; 52(2):195-7. PubMed ID: 23347307
[No Abstract] [Full Text] [Related]
30. The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer.
Monnier AM
Expert Rev Anticancer Ther; 2007 May; 7(5):627-34. PubMed ID: 17492927
[TBL] [Abstract][Full Text] [Related]
31. Aromatase inhibitors as adjuvant therapy for breast cancer: overall survival versus disease-free survival as a primary end point in clinical practice.
Sánchez-Muñoz A; Ribelles N; Márquez A; Pérez-Ruiz E; Alba E
J Clin Oncol; 2009 Dec; 27(35):e255-6; author reply e257-8. PubMed ID: 19884520
[No Abstract] [Full Text] [Related]
32. Clinical decision making in breast cancer: TAM and aromatase inhibitors for older patients -- a jungle?
Biganzoli L; Licitra S; Claudino W; Pestrin M; Leo AD
Eur J Cancer; 2007 Oct; 43(15):2270-8. PubMed ID: 17698345
[TBL] [Abstract][Full Text] [Related]
33. Elderly breast cancer patients treated by conservative surgery alone plus adjuvant tamoxifen: fifteen-year results of a prospective study.
Martelli G; Miceli R; Costa A; Coradini D; Zurrida S; Piromalli D; Vetrella G; Greco M
Cancer; 2008 Feb; 112(3):481-8. PubMed ID: 18098268
[TBL] [Abstract][Full Text] [Related]
34. A multidisciplinary approach to the management of breast cancer, part 2: therapeutic considerations.
Pruthi S; Boughey JC; Brandt KR; Degnim AC; Dy GK; Goetz MP; Perez EA; Reynolds CA; Schomberg PJ; Ingle JN
Mayo Clin Proc; 2007 Sep; 82(9):1131-40. PubMed ID: 17803883
[TBL] [Abstract][Full Text] [Related]
35. Safely promoting breast-conserving surgery and preventing early relapses with an aromatase inhibitor.
Markopoulos C
Surg Oncol; 2008 Aug; 17(2):113-28. PubMed ID: 18178077
[TBL] [Abstract][Full Text] [Related]
36. Local recurrence of breast cancer after skin-sparing mastectomy following core needle biopsy: case reports and review of the literature.
Uriburu JL; Vuoto HD; Cogorno L; Isetta JA; Candas G; Imach GC; Bernabo OL
Breast J; 2006; 12(3):194-8. PubMed ID: 16684314
[TBL] [Abstract][Full Text] [Related]
37. A breast cancer patient with myelodysplastic syndrome postoperatively treated by radiation and tamoxifen administration--a case report.
Mitani N; Sakuragi S; Matsuda K; Tanaka Y; Matsui K; Shinohara K
Gan To Kagaku Ryoho; 2006 Jun; 33(6):833-6. PubMed ID: 16770108
[TBL] [Abstract][Full Text] [Related]
38. Prospects of neoadjuvant aromatase inhibitor therapy in breast cancer.
Dixon JM
Expert Rev Anticancer Ther; 2008 Mar; 8(3):453-63. PubMed ID: 18366292
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant therapy with aromatase inhibitors for postmenopausal women with early breast cancer: evidence and ongoing controversy.
Wheler J; Johnson M; Seidman A
Semin Oncol; 2006 Dec; 33(6):672-80. PubMed ID: 17145347
[TBL] [Abstract][Full Text] [Related]
40. Does hormonal therapy have a therapeutic role in metastatic primary small cell neuroendocrine breast carcinoma? Case report and literature review.
Alkaied H; Harris K; Brenner A; Awasum M; Varma S
Clin Breast Cancer; 2012 Jun; 12(3):226-30. PubMed ID: 22424945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
